VALVANQ Trademark

Trademark Overview

On Wednesday, January 23, 2013, a trademark application was filed for VALVANQ with the United States Patent and Trademark Office. The USPTO has given the VALVANQ trademark a serial number of 79127632. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Tuesday, June 30, 2015. This trademark is owned by Novartis AG. The VALVANQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in oncology and hematology; diagnostic preparations for medical purposes
valvanq

General Information

Serial Number79127632
Word MarkVALVANQ
Filing DateWednesday, January 23, 2013
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateTuesday, June 30, 2015
Registration Number4427247
Registration DateTuesday, November 5, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 20, 2013

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in oncology and hematology; diagnostic preparations for medical purposes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateTuesday, June 30, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCH
Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCH

Trademark Events

Event DateEvent Description
Thursday, January 14, 2016NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Thursday, January 14, 2016DEATH OF INTERNATIONAL REGISTRATION
Friday, February 21, 2014FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, February 5, 2014FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, February 5, 2014FINAL DISPOSITION PROCESSED
Wednesday, February 5, 2014FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, November 5, 2013REGISTERED-PRINCIPAL REGISTER
Tuesday, August 20, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 20, 2013PUBLISHED FOR OPPOSITION
Wednesday, July 31, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, July 13, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, July 12, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 11, 2013EXAMINER'S AMENDMENT ENTERED
Thursday, July 11, 2013ASSIGNED TO LIE
Wednesday, July 10, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, July 10, 2013EXAMINERS AMENDMENT E-MAILED
Wednesday, July 10, 2013EXAMINERS AMENDMENT -WRITTEN
Monday, June 24, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 24, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, May 25, 2013REFUSAL PROCESSED BY IB
Tuesday, May 7, 2013NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, May 7, 2013REFUSAL PROCESSED BY MPU
Tuesday, May 7, 2013NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, May 6, 2013NON-FINAL ACTION WRITTEN
Friday, April 26, 2013ASSIGNED TO EXAMINER
Saturday, April 13, 2013APPLICATION FILING RECEIPT MAILED
Friday, April 12, 2013NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, April 9, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, April 8, 2013LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, April 4, 2013SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Related Keywords

valvanq preparations medical purposes diagnostic hematology oncology pharmaceutical